# Testosterone & Tamoxifen Trial

> **NCT05156606** · NA · TERMINATED · sponsor: **University Medical Center Groningen** · enrollment: 5 (actual)

## Conditions studied

- Male Breast Cancer

## Interventions

- **DRUG:** AndroGel

## Key facts

- **NCT ID:** NCT05156606
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-11-10
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Five patients were included; it did not succeed in recruiting the target number of 6 patients. This is as a result of the rarity of this disease in men.
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05156606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05156606, "Testosterone & Tamoxifen Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05156606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*